Publication | Closed Access

Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease

ObesityMetabolic SyndromeHepatologyHealth PolicyNonalcoholic Fatty Liver DiseaseOmega-3 Fatty AcidLiver PhysiologyLiver DiseaseWelcome TrialFatty Liver DiseaseMedicineHealth Sciences